ESC 365 - Outcome of histologically-proven fulminant versus acute non-fulminant myocarditis with left ventricular systolic dysfunction. Evidence from the International Registry on Acute Myocarditis

ESC Premium Access

Outcome of histologically-proven fulminant versus acute non-fulminant myocarditis with left ventricular systolic dysfunction. Evidence from the International Registry on Acute Myocarditis

Session: Diagnosis, management and prognosis in myocarditis

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor E. Ammirati (Milan, IT)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Enrico Ammirati

ASST Great Metropolitan Niguarda, Milan (Italy)

8 presentations

1 follower

4 more presentations in this session

Immunosuppressive therapy and prognosis in biopsy-proven fulminant lymphocytic myocarditis requiring veno-arterial extracorporeal membranous oxygenation support

Speaker: Doctor T. Okumura (Nagoya, JP)

Familial cardiomyopathy in patients affected by acute myocarditis is strongly associated to DSP gene mutations

Speaker: Doctor L. Marteau (Nantes, FR)

Long-term outcome of patients with biopsy-proven viral myocarditis: 12-year results from a late gadolinium enhancement cardiac magnetic resonance study

Speaker: Mr A. Seitz (Stuttgart, DE)

Evaluation of myocardial gene expression profiling for superior diagnosis of idiopathic giant cell myocarditis in a large cohort of patients with acute cardiac decompensation

Speaker: Doctor F. Escher (Berlin, DE)

Access the full session

Diagnosis, management and prognosis in myocarditis

Speakers: Doctor E. Ammirati, Doctor T. Okumura, Doctor L. Marteau, Mr A. Seitz, Doctor F. Escher

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources